Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 10/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6167303 | 0.86 | ALDH1A1 (0.45) | OPRM1SRCHTTKDM4EALDH1A1 | |
| SCHEMBL6770286 | 0.83 | OPRM1 (0.56) | OPRM1SRCHTTKDM4EALDH1A1 | |
| SCHEMBL6766781 | 0.80 | OPRM1 (0.54) | OPRM1SRC | |
| SCHEMBL6771234 | 0.80 | CSNK2A2 (0.35) | OPRM1HTTALDH1A1 | |
| SCHEMBL6767074 | 0.79 | OPRM1 (0.41) | OPRM1SRCGRIA2CYP1A2CYP2C9 | |
| SCHEMBL6767118 | 0.79 | HTT (0.40) | OPRM1SRCGRIA2HTTKDM4E | |
| SCHEMBL6772487 | 0.79 | SRC (0.53) | OPRM1SRCHTTKDM4EALDH1A1 | |
| SCHEMBL6766716 | 0.78 | HTT (0.37) | OPRM1SRCGRIA2HTTALDH1A1 | |
| SCHEMBL6771178 | 0.77 | SRC (0.43) | OPRM1SRCGRIA2HTTKDM4E | |
| SCHEMBL6776541 | 0.77 | ALDH1A1 (0.47) | OPRM1SRCCYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6716856-B1 | CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY | PHARMACIA & TUBJOHN SPA (IT) | 2004-04-06 | — | — | US | disclosed |